BIOMAT Database Logo BIOMAT Database Logo

[Therapeutic considerations on the hypoglycemic action of buclizine (Postafen)]. 1966

E Castellar, and G de Melo, and R Sales, and A Gonçalves

UI MeSH Term Description Entries
D007004 Hypoglycemic Agents Substances which lower blood glucose levels. Antidiabetic,Antidiabetic Agent,Antidiabetic Drug,Antidiabetics,Antihyperglycemic,Antihyperglycemic Agent,Hypoglycemic,Hypoglycemic Agent,Hypoglycemic Drug,Antidiabetic Agents,Antidiabetic Drugs,Antihyperglycemic Agents,Antihyperglycemics,Hypoglycemic Drugs,Hypoglycemic Effect,Hypoglycemic Effects,Hypoglycemics,Agent, Antidiabetic,Agent, Antihyperglycemic,Agent, Hypoglycemic,Agents, Antidiabetic,Agents, Antihyperglycemic,Agents, Hypoglycemic,Drug, Antidiabetic,Drug, Hypoglycemic,Drugs, Antidiabetic,Drugs, Hypoglycemic,Effect, Hypoglycemic,Effects, Hypoglycemic
D008297 Male Males
D010629 Phenformin A biguanide hypoglycemic agent with actions and uses similar to those of METFORMIN. Although it is generally considered to be associated with an unacceptably high incidence of lactic acidosis, often fatal, it is still available in some countries. (From Martindale, The Extra Pharmacopoeia, 30th ed, p290) Fenformin,Phenylethylbiguanide
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D011236 Prediabetic State The time period before the development of symptomatic diabetes. For example, certain risk factors can be observed in subjects who subsequently develop INSULIN RESISTANCE as in type 2 diabetes (DIABETES MELLITUS, TYPE 2). Prediabetes,Prediabetic States,State, Prediabetic,States, Prediabetic
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D005260 Female Females
D005951 Glucose Tolerance Test A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg). Intravenous Glucose Tolerance,Intravenous Glucose Tolerance Test,OGTT,Oral Glucose Tolerance,Oral Glucose Tolerance Test,Glucose Tolerance Tests,Glucose Tolerance, Oral
D006634 Histamine H1 Antagonists Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. Antihistamines, Classical,Antihistaminics, Classical,Antihistaminics, H1,Histamine H1 Antagonist,Histamine H1 Receptor Antagonist,Histamine H1 Receptor Antagonists,Histamine H1 Receptor Blockaders,Antagonists, Histamine H1,Antagonists, Histamine H1 Receptor,Antihistamines, Sedating,Blockaders, Histamine H1 Receptor,First Generation H1 Antagonists,H1 Receptor Blockaders,Histamine H1 Blockers,Receptor Blockaders, H1,Antagonist, Histamine H1,Classical Antihistamines,Classical Antihistaminics,H1 Antagonist, Histamine,H1 Antagonists, Histamine,H1 Antihistaminics,Sedating Antihistamines

Related Publications

E Castellar, and G de Melo, and R Sales, and A Gonçalves
[Clinical findings on the hypoglucemic action of buclizine].
January 1966, Prensa medica argentina,
E Castellar, and G de Melo, and R Sales, and A Gonçalves
[Lacticemia and pyruvemia in the hypoglycemic effect of buclizine (Postafen)].
December 1968, Hospital (Rio de Janeiro, Brazil),
E Castellar, and G de Melo, and R Sales, and A Gonçalves
[Clinical considerations on the hypoglycemic action of an orally administered sulfamide derivative].
October 1956, Minerva medica,
E Castellar, and G de Melo, and R Sales, and A Gonçalves
[Therapeutic action of postinsulin light hypoglycemic states].
January 1954, Polskie Archiwum Medycyny Wewnetrznej,
E Castellar, and G de Melo, and R Sales, and A Gonçalves
[Clinical considerations on the therapeutic action of Nucleodoxine].
January 1968, Omnia medica et therapeutica,
E Castellar, and G de Melo, and R Sales, and A Gonçalves
[Considerations on therapeutic action of segmental arterial resection].
January 1951, Archivos uruguayos de medicina, cirugia y especialidades,
E Castellar, and G de Melo, and R Sales, and A Gonçalves
[On a hypoglycemic action of anabolic steroids. Presentation of a case; verification and considerations].
April 1962, Minerva medica,
E Castellar, and G de Melo, and R Sales, and A Gonçalves
[ACTION OF HYPOGLYCEMIC DRUGS ON THE LIVER].
January 1963, Revista de la Sociedad Argentina de Biologia,
E Castellar, and G de Melo, and R Sales, and A Gonçalves
[Action of hypoglycemic drugs on the stomach].
March 1963, La Semana medica,
E Castellar, and G de Melo, and R Sales, and A Gonçalves
[Research on the hypoglycemic action of PAS].
February 1952, Rassegna medica,
Copied contents to your clipboard!